D. Geng

发表

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

H. Einsele, S. Jagannath, A. Jakubowiak, 2022, Blood Cancer Journal.

[Chondrocyte apoptosis and the expression of Bcl-2, Bax, Fas and iNos in articular cartilage in Kashin-Beck disease].

Xiong Guo, P. Xu, Yin-gang Zhang, 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[Serum hyaluronic acid, tumor necrosis factor -alpha, vascular endothelial growth factor, NO, and Se levels in adult patients with Kashin-Beck disease].

Xiong Guo, Xiao-ying Li, Shuang Wang, 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Anti-drug Antibody Validation Testing and Reporting Harmonization

Troy E. Barger, M. Hodsdon, R. Bowsher, 2021, The AAPS Journal.

Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.

K. O'Neil, R. Sweet, M. Tornetta, 2007, Journal of immunological methods.

Expression of miR-4739 in Gastric cancer and its Relationship with Clinical Pathological Features of Patients

Jun Yu Li, Hui-Chen Wu, D. Geng, 2022, Frontiers in Surgery.

Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine

L. A. Snyder, Stephen G McCarthy, A. Schantz, 2005, Cancer Immunology, Immunotherapy.

Volumetric absorptive microsampling (VAMS®) in therapeutic protein quantification by LC-MS/MS: Investigation of anticoagulant impact on assay performance and recommendations for best practices in method development.

K. Bateman, E. Woolf, S. Shi, 2021, Journal of pharmaceutical and biomedical analysis.

Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses1

D. Sachs, J. Madsen, M. Sayegh, 2000, The Journal of Immunology.

Responses and Xenogeneic Human Anti-Porcine T Cell Prevents Costimulation of Allogeneic Porcine Blockade of CD28-B7, But Not CD40-CD154,

D. Sachs, J. Madsen, M. Sayegh, 2000 .

Xenogeneic Human Anti-Porcine T Cell Prevents Costimulation of Allogeneic Porcine Blockade of CD 28B 7 , But Not CD 40-CD 154 ,

D. Sachs, J. Madsen, M. Sayegh, 2000 .

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

S. Jagannath, A. Jakubowiak, N. Munshi, 2021, The Lancet.

Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease.

Xiong Guo, Peng Xu, Dong Geng, 2006, The Journal of rheumatology.

Abnormal expression of Col X, PTHrP, TGF-β, bFGF, and VEGF in cartilage with Kashin–Beck disease

Xiong Guo, Dong Geng, Yan Zhang, 2006, Journal of Bone and Mineral Metabolism.

CARTITUDE-2: Efficacy and Safety of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy, in Patients with Multiple Myeloma and Early Relapse after Initial Therapy

P. Sonneveld, M. Vogel, M. Delforge, 2021, Blood.

Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.

S. Jagannath, A. Jakubowiak, J. Goldberg, 2020 .

Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats.

D. Geng, Y. Yu, H. Zuo, 2007, Osteoarthritis and cartilage.

[Comparison of apoptosis of articular chondrocytes in the pathogenesis of Kashin-beck disease and primary osteoarthritis].

Xiong Guo, Yin-gang Zhang, D. Geng, 2006, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

Associations Between Selenium Content in Hair and Kashin-Beck Disease/Keshan Disease in Children in Northwestern China: a Prospective Cohort Study

Xiong Guo, M. Lammi, Fengshi Chen, 2017, Biological Trace Element Research.

Detection of serum proteomic changes and discovery of serum biomarkers for Kashin-Beck disease using surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS)

Xiong Guo, Wu-hong Tan, Xun Qu, 2008, Journal of Bone and Mineral Metabolism.

Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R MM), Indicates Preferential Expansion of CD8+ T Cell Central Memory Cell Subset

S. Jagannath, A. Jakubowiak, J. Goldberg, 2019, Blood.

[Analysis of genetic polymorphism of 7 STR loci on chromosome 12 in Shaanxi Han populations].

Xiong Guo, J. Lai, D. Geng, 2005, Yi chuan = Hereditas.

CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

S. Jagannath, A. Jakubowiak, N. Munshi, 2020 .

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

Dianna Y. Wu, Jinshan Shen, E. Masson, 2013, Clinical Drug Investigation.

Efficacy and Safety of Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 Subgroup Analysis

S. Jagannath, A. Jakubowiak, P. Hari, 2021, Blood.

Ciltacabtagene Autoleucel (Cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients with Multiple Myeloma (MM) and Early Relapse after Initial Therapy: CARTITUDE-2 Cohort B 18-Month Follow-up

P. Sonneveld, L. Pacaud, E. Zudaire, 2022, Blood.

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies.

G. Shankar, C. Wagner, H. Davis, 2005, Journal of pharmaceutical and biomedical analysis.

[Analysis of allele frequencies of 6 short tandem repeat loci on chromosome 12 in patients with Kashing-Beck disease].

Xiong Guo, J. Lai, D. Geng, 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFTER INITIAL THERAPY

P. Sonneveld, D. Madduri, L. Pacaud, 2023, HemaSphere.

Preclinical assessment of LCAR-B38M, a novel BCMA-targeting chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory multiple myeloma

D. Geng, Dan-dan Zhao, Yang Lei, 2019, Clinical Lymphoma Myeloma and Leukemia.

1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development

K. Vora, A. Aliprantis, Ghassan N. Fayad, 2018, Open Forum Infectious Diseases.